{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16224", "batch_size": 200, "batch_pos": 124, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 2, "answer": "no", "rationale": "The segment describes an activity factually ('has begun scaling up', 'testing of samples') and does not contain a high-potency verb, potent metaphor, or other Q2 cues.", "method": "llm_batch", "batch_id": "batch_2_20960", "batch_size": 193, "batch_pos": 83, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 3, "answer": "no", "rationale": "The segment contains scales ('190 sites', '36 states') but not paired with a moderate verb indicating impact.", "method": "llm_batch", "batch_id": "batch_3_19384", "batch_size": 200, "batch_pos": 187, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_13052", "batch_size": 200, "batch_pos": 177, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 5, "answer": "no", "rationale": "Factual report on action.", "method": "llm_batch", "batch_id": "batch_5_3168", "batch_size": 200, "batch_pos": 172, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 6, "answer": "no", "rationale": "No minimiser token found. '190 sites', '36 states' are numbers, not minimisers.", "method": "llm_batch", "batch_id": "batch_6_18340", "batch_size": 200, "batch_pos": 121, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 7, "answer": "no", "rationale": "No bare negation found.", "method": "llm_batch", "batch_id": "batch_7_1968", "batch_size": 189, "batch_pos": 92, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
{"Q": 8, "answer": "yes", "rationale": "Describes an action to increase capability ('has begun scaling up H5-specific testing').", "method": "llm_batch", "batch_id": "batch_8_17168", "batch_size": 115, "batch_pos": 35, "statement_text": "WastewaterSCAN, an infectious disease-tracking sewage surveillance network led by Stanford University and Emory University in partnership with Verily Life Sciences, has begun scaling up H5-specific testing of samples from all of its 190 sites at treatment plants across 36 states.", "article_id": 582}
